Bluejay Diagnostics, Inc. (BJDX)
About Bluejay Diagnostics, Inc.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2022
- $249.0K
- Net income
- -$6.8M
- Total assets
- $7.1M
- Market cap
- $5.0M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $7.0M
- Operating income
- -$7.0M
- Income tax
- $31.3M
- Net income
- -$6.8M
- EPS (basic)
- $-15.25
- EPS (diluted)
- $-15.25
Balance sheet
- Total assets
- $7.1M
- Current assets
- $5.5M
- Total liabilities
- $1.1M
- Current liabilities
- $1.1M
- Shareholders’ equity
- $6.0M
Cash flow
- Operating cash flow
- -$6.1M
- Investing cash flow
- -$173.7K
- Financing cash flow
- $7.1M
- Net cash flow
- $862.9K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $5.0M
- EPS (diluted)
- $-15.25
- Shares outstanding
- 4.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 10, 2021
Bluejay Diagnostics, Inc. (BJDX) Stock Price
- Reported a net loss of $6.8M in FY2022.
- Trading 93% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Bluejay Diagnostics, Inc..
Write a review
News about Bluejay Diagnostics, Inc.
News & sentiment via Polygon.io
Bluejay Diagnostics, Inc.: frequently asked questions
Is Bluejay Diagnostics, Inc. an American company?
Bluejay Diagnostics, Inc. is a US-based company headquartered in Acton, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Bluejay Diagnostics, Inc. headquartered?
Bluejay Diagnostics, Inc. is headquartered in Acton, Massachusetts, United States.
Is Bluejay Diagnostics, Inc. publicly traded?
Yes — Bluejay Diagnostics, Inc. is a publicly traded company. Its stock trades under the ticker symbol BJDX on the NASDAQ.
What does Bluejay Diagnostics, Inc. do?
Bluejay Diagnostics, Inc. is an American Medical Devices company in the Health & Beauty sector.
